Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
NCT01675089
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Renal Osteodystrophy
Interventions
DRUG:
Zoledronic acid
Sponsor
University of Sao Paulo General Hospital